For instance, sorafenib resistance (both primary and acquired), in which upregulation of NRF2-related signaling pathway in cancer cells plays a core role, is considered to be the main cause of poor prognosis in HCC patients. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.